2Wakai K,Tamakoshi A,Ikezaki K,et al.Epidemiological features of moyamoya disease in Japan:findings from a nationwide survey[J].Clin Neurol Neurosurg,1997,99Suppl 2:1-5.
3Kuriyama S,Kusaka Y,Fujimura M,et al.Prevalence and clinicoepidemiological features of moyamoya disease in Japan:findings from a nationwide epidemiological survey[J].Stroke,2008,39(l):42-47.
4Baba T,Houkin K,Kuroda S.Novel epidemiological features of moyamoya disease[J].J Neurol Neurosurg Psychiatry,2008,79 (8):900-904.
5Yonekawa Y,Ogata N,Kaku Y,et al.Moyamoya disease in Europe,past and present status[J].Clin Neurol Neurosurg,1997,99 Suppl 2:58-60.
6Uchino K,Johnston SC,Becker KJ,et al.Moyamoya disease in Washington State and California[J].Neurology,2005,65 (6):956-958.
7Miao W,Zhac PL,Zhang YS,et al.Epidemiological and clinical features of Moyamoya disease in Nanjing,China[J].Clin Neurol Neurosurg,2010,112 (3):199-203.
8Hung CC,Tu YK,Su CF,et al.Epidemiological study of moyamoya disease in Taiwan.Clin Neurol Neurosurg[J],1997,99 Suppl 2:23-25.
9lkezaki K,Han DH,Kawano T,et al.A clinical comparison of definite moyamoya diseases between South Korea and Japan[J].Stroke,1997,28(12):2513-2517.
10Duan L,Bao XY,Yang WZ,et al.Moyamoya disease in China:Its clinical features and outcomes[J].Stroke,In press 2011.
3Smith R, Scott M. Surgical management of Moyamoya syndrome [J]. Skull Base, 2005, 15(1): 15-26.
4Matsushima Y. Moyamoya disease. In: Youmans JR ed. Neurological Surgery [M]. Vol4. 4th ed. Philadephia: W B Saunders Co, 1996. 1202-1223.
5Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (Moyamoya disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan [J]. Clin Neurol Neurosurg, 1997, 99(suppl 2): s238-240.
6Ikezaki K, Han DH, Kawano T, et al . A clinical comparison of definite moyamoya diseases between South Korea and Japan [J]. Stroke, 1997, 28: 2513-2517.
7Tenjin H, Ueda S. Multiple EDAS (eneephalo-duro-arterio- synangiosis). Additional EDAS using the frontal branch of the superficial temporal artery (STA) and the occipital artery for pediatric moyamoya patients in whom EDAS using the parietal branch of STA was insufficient [J]. Child's Nerv Syst, 1997, 13: 220-224.
8Tripathi P, Tripathi V, Naik RJ, et al . Moyamoya cases treated with encephaloduroarteriosynangiosis [J]. Indian Pediatr, 2007, 44: 123-127.
9Kim SK, Wang KC, Kim IO, et al . Combined encephalo- duroarteriosynangiosis and bifrontal encephalogaleo (periosteal) synangiosis in pediatric Moyamoya disease [J]. Neurosurgery, 2002, 50: 88-96.
10Kim DS, Yoo DS, Huh PW, et al . Combined direct anasto-mosis and encephaloduroarteriogaleosynangiosis using inverted superficial temporal artery-galeal flap and superficial temporal artery-galeal pedicle in adult Moyamoya disease [J]. Surg Neurol, 2006, 66: 389N395.
3Suzuki J,Takaku A.Cerebrovascular "moyamoya"disease: disease showing abnormal net-like vessels in base of brain[J].Arch Neurol, 1969,20:288-299.
4Miao W,Zhao P L,zhang Y S,et al.Epidemidogical and clinical features of moyamoya disease in Nanjing,China [ J ].Clin Neurol Neurosurg,2010,112 (3): 199-203.
5Fukui M.Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of willis (moyamoya disease ).Research committee on spontaneous occlusion of the circle of willis (moyamoya disease) of the ministry of health and welfare Japan[J].Clin Neurol Neuresurg,1997, 99(S 2):238-240.
6Kuriyama S, Kusaka Y,Fujimura M,et al.Prevalence and clinicoepidemiological features of moyamoya disease in Japan:findings from a nationwide epidemiological survey [J ].Stroke,2008,39( 1 ):42-47.
7Yonekawa Y,Ogata N,Kaku Y,et al.Moyamoya disease in Europe,past and present states [J].Clin Neurol Neurosurg, 1997,99(S 2):58-60.
8Ikeda K,Iwasaki Y, Kashihara H,et al.Aduh moyamoya disease in the asymptomatic japanese population [J].J Clin Neurosci,2006,13 (3):334-338.
